2014, Number 3
<< Back Next >>
Revista Cubana de Salud y Trabajo 2014; 15 (3)
Prevalence of viral hepatitis B and C in workers of the Institute of Gastroenterology, Havana
Hernández AR, Castellanos FMI, Folgueira MRM, Cendan CA, Turcaz BN
Language: Spanish
References: 27
Page: 24-30
PDF size: 257.40 Kb.
ABSTRACT
Introduction: The health workers are a risk group for infection with hepatitis viruses B and C.
Objective: To determine the current status of this problem in health care workers of the Institute of Gastroenterology.
Material and methods: A prevalence study was conducted in 180 workers with an average age of 41,5 ± 10.9 years during the period 2011-2012, and an average working time in the center of approximately 10 years.
Results: The prevalence of infection with hepatitis B virus was low (1,7 %) and the overall seroprevalence for hepatitis C virus was intermediate (2,2 %). Workers of general services were the most affected and occupational risk factors considered were not identified as probable routes of transmission. The seroprotection for hepatitis B was low, despite being mostly immunized previously.
Conclusions: Infection with hepatitis viruses B and C was not a health problem for workers in the institution; however, it is wise to exercise extreme control and compliance measures of protection and safety as well as revitalize the established immunization program for hepatitis B virus.
REFERENCES
World Health Organization [Internet]. The World Health Report, Box 4.4. 2002. Geneva, Switzerland: [acceso 20 Jun 2013]. Disponible en: http://www.who.int/whr/2002/chapter4/en/index8.html.
Wilburn S, Eijkemans G. La prevención de pincha-zos con agujas en el personal de salud. Una colabo-ración entre OMS-CIE. Int J Occup Environ Health. 2004;10: 451–56.
Warley E, Desse J, Szyld E, Silva FN, Cetani S, Pereyra N et al. Occupational exposure to hepatitis C virus. Medicina (B Aires). 2006;66(2):97-100.
Vardas E, Ross M, Sharp G, McAnerney J, Sim J. Viral hepatitis in South African healthcare workers at increased risk of occupational exposure to blood-borne viruses. Journal of Hospital Infection. 2002;50:6-12.
Franka E, El-Zoka AH, Hussein AH, Elbakosh MM, Arafa AK, Ghenghesh KS. Hepatitis B virus and hepatitis C virus in medical waste handlers in Trip-oli, Libya. Journal of Hospital Infection. 2009;72: 258-61.
Suckling RM, Taegtmeyer M, Nguku PM, Al-Abri SS, Kibaru J, Chakaya JM, et al. Susceptibility of health care workers in Kenya to hepatitis B: new strategies for facilitating vaccination uptake. Journal of Hospital Infection. 2006;64:271-77
Gerberding JL. Incidence And prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care per-sonnel at risk for blood exposure: Final report from a longitudinal Study. J Infect Dis. 1994;170 (6): 1410-17
Wood A. Management of occupational exposures to blood-borne viruses. N Engl J Med. 1995;332:444-51.
Arús E, Negrín R. Prevalencia de los marcadores del virus de la hepatitis B en personal de alto riesgo de un hospital general. Rev Cub Med Mil.1992;21(1): 43-9.
Ramírez V, González A, Alerm A, Vega I, Pentón E, González M. Seguridad e inmunogenicidad de la vacuna cubana Heberbiovac Hb en poblaciones de América, Europa, África y Asia. Rev Cubana Invest Biomed. 2000;19(1):26-32
Anuario estadístico de salud 2012 [Internet]. La Habana: Ministerio de Salud Pública. Dirección Na-cional de Registros Médicos y Estadísticas de Salud; 2012 [acceso 27 Jun 2013]. Disponible en: www.sld.cu/sitios/dne/.
Sleisenger, Fordtran. Enfermedades gastrointestinales y hepáticas. Fisiopatología, diagnóstico y tratamiento. 7ª ed. Editorial Médica Panamericana; 2002. p. 1354-22.
De la Hoz F. Epidemiología de la hepatitis C en Latinoamérica y Colombia. Instituto Nacional de Sa-lud, Bogotá Colombia. Biomédica.2000;20(001): 66-72.
Thomas D, Factor SH, Kelen GD, Washington AS, Taylor E, Quinn T. The seroprevalence and risk fac-tors for hepatitis B virus and hepatitis C virus infec-tion in health care personnel at the Johns Hopkins Hospital. Arch Intern Med. 2003;153(14):1705-12.
Gerberding JL, Prevalence of hepatitis C in health workers: Final report from a longitudinal study. Oxford Journals Medicine. 2009;170(6):1410-7.
Ballester JM: El Programa de Medicina Transfusio-nal en Cuba. Revista Panamericana de Salud Pública. 2003;13:2-7.
Robaina C, Sevilla D. Epidemiología de las enfer-medades relacionadas con la ocupación. Rev Cubana Med Gen Integr. 2003;19:2-4.
Junco R, Martinez G, Luna MV. Seguridad ocupa-cional en el manejo de los desechos peligrosos en instituciones de salud. Rev Cubana Hig Epidemiol. 2003;41(1).
19.World Health Organization. Safe management of wastes from health-care activities. Geneva: WHO; 1999.
Reinhardt PA, Gordon KG. Infectious and medical waste management. Michigan: Lewis Publishers Inc.; 1991.
Coad A. Manejo de desechos médicos en países en desarrollo. Informe de consultoría. Washington DC: Organización Mundial de la Salud; 1996.
22.WHO [Internet]. Salud mundial de los trabajadores. Health Assembly [acceso 28 Jun de 2013]. Disponible en: http://www.who.int/ocupational health 2007.
Ballester JM, Rivero RA, Villaescusa R, Merlín JC, Arce AA, Castillo D, et al. Hepatitis C virus antibod-ies and other markers of blood-transfusion-transmitted infection in multi-transfused Cuban pa-tients. J Clin Virol. 2005;34 Suppl 2:S39-46.
Martínez A, Pulido A, Ruiz Y, Camacho JA. Com-portamiento de la infección por el virus de la hepati-tis C en el Hospital Provincial de Ciego de Ávila du-rante el quinquenio 2005-2010. Mediciego. 2011;17(1).
Torres M, Lang F, Toledo G. Prevalencia del antí-geno de superficie de la hepatitis B, en el área de sa-lud "Raúl Sánchez". Rev Cubana Hig Epidemiol. 2001;39(1).
García P, de las Cerdas G, Calvo M, Godoy R, Co-varrubias C, Potin M, et al. Inmunogenicidad de una vacuna recombinante anti hepatitis B en personal de salud. Rev Chil Infect. 2002;19(3):133-9-
Zumaeta E, González Griego A, Ferrandiz J, Villanueva A, Soto V, Almeida R, et al. Predicted duration of protective anti-HBs antigens in Peruvian health care workers after six years of vaccination. Rev Gastroenterol Peru. 2001;21(4):276-81.